Randomized trial · people

LL-37: no healing gain over placebo for venous leg ulcers overall

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In this trial, LL-37 on the skin did not help venous leg ulcers heal overall; a possible benefit in large ulcers is still unconfirmed.

Kind
Randomized trial
Studied in
People
Number studied
148
Published
2021
Journal
Wound Repair Regen

What they tested

Does LL-37 put on the skin, together with compression bandaging, help hard-to-heal venous leg ulcers heal better than placebo, and is it safe?

How the study was done

A phase IIb double-blind, randomized, placebo-controlled trial at several centers in 148 patients with hard-to-heal venous leg ulcers, all also getting compression therapy. Patients got LL-37 at 0.5 or 1.6 mg/mL or a placebo (a dummy treatment); their mean age was 67.6 years, ulcers had lasted a median of 20.3 months, and mean wound size was 11.6 cm2.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking LL-37? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Across all patients, neither LL-37 arm healed ulcers significantly better than placebo. In a post hoc analysis, a look back at a subgroup chosen after the trial, patients whose wounds measured at least 10 cm2 at the start showed statistically significant gains on several linked healing measures with LL-37. Both strengths were well tolerated and safe.

What it doesn’t show

The trial missed its main goal in the full group, and the large-wound benefit comes from a post hoc subgroup analysis the trial was not designed or sized to test. The researchers say a new trial sized for patients with large ulcers is needed.

The paper

Mahlapuu et al. Evaluation of LL-37 in healing of hard-to-heal venous leg ulcers: A multicentric prospective randomized placebo-controlled clinical trial. Wound Repair Regen. 2021.

The compound

More studies on LL-37

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking LL-37? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo